Anti-α-fodrin antibodies in Sjogren syndrome and lupus erythematosus

Archives of Dermatology

Volumn 135, Issue 5, 1999, Pages 535-539

  Watanabe, Takahiro ^a   Tsuchida, Tetsuya ^b   Kanda, Naoko ^a   Mori, Katsunori ^a   Hayashi, Yoshio ^c   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; COLD INJURY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERIMMUNOGLOBULINEMIA; JAPAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SEROPREVALENCE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AUTOANTIBODIES; CARRIER PROTEINS; CHILD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 0032947336     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.5.535     Document Type: Article

References (39)

1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
2. European Community Study Group on Diagnostic Criteria for Sjögren's Syndrome. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36:340-347.
3. Scopelitis E, Biundo JJ Jr, Alspaugh MA. Anti-SS-A antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum. 1980;23: 287-293.
4. Harley JB, Alexander EL, Bias WB, et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum. 1986;29:196-206.
5. Reichlin M. Significance of the Ro antigen system. J Clin Immunol. 1986;6:339-348.
6. Ben-Chetrit E. The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies. Br J Rheumatol. 1993;32:396-402.
7. Ben-Chetrit E, Pollard KM. Purified 60-kD SSA/Ro recombinant protein: an antigenic source for ELISA screening of patients with rheumatic diseases. J Clin Lab Immunol. 1990;32:195-200.
8. Provost TT, Talal N, Harley JB, Reichlin M, Alexander E. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus. Arch Dermatol. 1988;124:63-71.
9. Teramoto N, Katayama I, Arai H, et al. Annular erythema: a possible association with primary Sjögren's syndrome. J Am Acad Dermatol. 1989;20:596-601.
10. Ruzicka T, Faes J, Bergner T, Peter RU, Braun-Falco O. Annular erythema associated with Sjögren's syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol. 1991;25:557-560.
11. Watanabe T, Tsuchida T, Ito Y, Kanda N, Ueda Y, Tamaki K. Annular erythema associated with lupus erythematosus/Sjögren's syndrome. J Am Acad Dermatol. 1997;36:214-218.
12. McCauliffe DP, Faircloth E, Wang L, Hashimoto T, Hoshino Y, Nishikawa T. Similar Ro/SS-A autoantibody epitope and titer responses in annular erythema of Sjögren's syndrome and subacute cutaneous lupus erythematosus. Arch Dermatol. 1996;132:528-531.
13. Haneji N, Nakamura T, Takio K, et al. Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science. 1997;276:604-607.
14. Perrin D, Aunis D. Reorganization of α-fodrin induced by stimulation in secretory cells. Nature. 1985;315:589-592.
15. Perrin D, Langley OK, Aunis D. Anti-α-fodrin inhibits secretion from permeabilized chromaffin cells. Nature. 1987;326:498-501.
16. Ménard HA, El-Amine M. The calpain-calpastatin system in rheumatoid arthritis. Immunol Today. 1996;17:545-547.
17. Després N, Talbot G, Plouffe B, Boire G, Ménard HA. Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest. 1995;95:1891-1896.
18. Mimori T, Suganuma K, Tanami Y, et al. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci U S A. 1995;92:7267-7271.
19. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol. 1979;115:1409-1415.
20. Ropes MW, Bennett GA, Cobb S. Diagnostic criteria for rheumatoid arthritis: 1958 revision. Bull Rheum Dis. 1958;9:175-176.
21. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23: 581-590.
22. McCauliffe DP, Yin H, Wang L, Lucas L. Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro (SSA) proteins. J Rheumatol. 1994; 21:1073-1080.
23. McCauliffe DP, Wang L, Satoh M, Reeves WH, Small D. Recombinant 52-kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays. J Rheumatol. 1997;24:860-866.
24. Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest. 1975;55:1067-1073.
25. Moon RT, McMahon AP. Generation of diversity in nonerythroid spectrins. J Biol Chem. 1990;265:4427-4433.
26. Qadri I, Maguire HF, Siddiqui A. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci U S A. 1995;92:1003-1007.
27. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4354.
28. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med. 1983;309:209-212.
29. Lockshin MD, Bonfa E, Elkon K, Druzin ML. Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus. Arthritis Rheum. 1988;31:697-701.
30. Alexander EL, Provost TT. Cutaneous manifestations of primary Sjögren's syndrome: a reflection of vasculitis and association with anti-Ro (SSA) antibodies. J Invest Dermatol. 1983;80:386-391.
31. Alexander EL, Arnett FC, Provost TT, Stevens MB. Sjögren's syndrome: association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities and serologic hyperreactivity. Ann Intern Med. 1983;98:155-159.
32. Ben-Chetrit E, Fox RI, Tan EM. Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus. Arthritis Rheum. 1990;33:349-355.
33. Reichlin M, Harley JB. Antibodies to Ro (SSA) and the heterogeneity of systemic lupus erythematosus. J Rheumatol. 1987;14(suppl 13):112-117.
34. Mond CB, Peterson MGE, Rothfield NF. Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum. 1989; 32:202-204.
35. Maddison PJ, Mogavero H, Provost TT, Reichlin M. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue disease. J Rheumatol. 1979;6:189-195.
36. Hedgpeth MT, Boulware DW. Antibodies to SS-A (Ro) and interstitial lung disease in systemic lupus erythematosus (SLE). Arthritis Rheum. 1987;30(suppl): S85.
37. Slobbe RL, Pruijn GJM, Damen WGM, Van der Kemp WCM, van Venrooij WJ. Detection and occurrence of the 60- and 52-kO Ro (SS-A) antigens and of autoantibodies against these proteins. Clin Exp Immunol. 1991;86:99-105.
38. St. Clair EW, Burch JA Jr, Saitta M. Specificity of autoantibodies for recombinant 60-kd and 52-kd Ro autoantigens. Arthritis Rheum. 1994;37:1373-1379.
39. Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol. 1993;100:58S-68S.